WeVote
Log In

Bill

Bill

HB 2182

Creating a data dashboard to track use of regulated substances.

2023-2024 Regular Session Introduced by Lisa Callan and 5 co-sponsors

Washington establishes a data tracking dashboard for regulated substances to monitor distribution patterns and inform public health and law enforcement responses.

By resolution, returned to House Rules Committee for third reading.
0
WeVote Research Nonpartisan
Bill Summary · HB 2182

Legislative bill overview

HB 2182 establishes a data dashboard system in Washington state to track the use and distribution of regulated substances. The bill appears designed to create transparency and monitoring capabilities for controlled or restricted substances through centralized data collection and public or authorized access to usage patterns.

Why is this important

Real-time tracking systems for regulated substances can help state agencies identify abuse patterns, diversion of pharmaceuticals, and public health trends more quickly than traditional reporting methods. This data infrastructure supports evidence-based policy decisions and can inform law enforcement and public health responses to emerging substance use crises.

Potential points of contention

  • Privacy concerns: Tracking individual or pharmacy-level substance usage raises questions about data security, who can access the information, and whether adequate safeguards exist to prevent misuse or unauthorized disclosure
  • Implementation costs: Building and maintaining a comprehensive statewide dashboard requires significant IT infrastructure, staffing, and ongoing operational expenses that may strain agency budgets
  • Scope ambiguity: The bill's specific definition of "regulated substances" and which industries/entities must report data could create compliance confusion and unequal burden across different regulated sectors

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.